In a study of ischemia/reperfusion injury, a potent metabolically stable PACAP38 analog [acetyl-(Ala15, Ala20) PACAP38-propylamide] led to the same degree of protection as native PACAP38 [46]. The gene discussed is ADCYAP1; the disease is ischemia reperfusion injury.